跳至主要内容
临床试验/CTRI/2017/10/010069
CTRI/2017/10/010069招募中3 期

Efficacy of Mycophenolate Mofetil (MMF) as compared to Methotrexate for disease remission in Takayasu arteritis

IPCA Laboratories Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of Takayasu arteritis as per ACR/ Ishikawa criteria

排除标准

  • Those who are on Azathioprine, MMF Methotrexate for more than 1 week, received Tocilizumab in the last 6 weeks
  • Prednisolone at doses more than 10 mg for more than a month
  • Pregnant ladies
  • Any contraindication to MMF or Methotrexate (pre-existing renal or liver disease)
  • However those who are on suboptimal doses of these medications and are still active at the time of presentation will be recruited.

研究者

相似试验